Bay Street News, January 3rd, 2024

MONTREAL, Jan. 03, 2024 (GLOBE NEWSWIRE) — Troilus Gold Corp. (TSX: TLG; OTCQX: CHXMF; FSE: CM5R) (“Troilus” or the “Company”) […]

TORONTO, Jan. 03, 2024 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; NASDAQ: POET), the designer and […]

VANCOUVER, British Columbia , Jan. 03, 2024 (GLOBE NEWSWIRE) — Anfield Energy Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” […]

CALGARY, Alberta, Jan. 03, 2024 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX […]

LIVONIA, Mich., Jan. 03, 2024 (GLOBE NEWSWIRE) — Alta Equipment Group Inc. (NYSE: ALTG) (“Alta” or “the Company”), a leading […]

BEDMINSTER, N.J., Jan. 03, 2024 (GLOBE NEWSWIRE) — Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on redefining […]

The Botanist products expected to hit participating adult-use dispensary shelves the week of January 8th Full menu of The Botanist […]

Topline data from LIFT-AD on track for second half of 2024 Previously reported independent, unblinded interim analysis supports trial continuation […]

FOSTER CITY, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a clinical-stage biopharmaceutical […]

Loughborough, UK, Jan. 03, 2024 (GLOBE NEWSWIRE) — Nemaura Medical Inc. (“Nemaura Medical” or the “Company”), developer of a daily […]